PROSTATE CANCER RESEARCH INSTITUTE AND FOUNDATION FOR CANCER RESEARCH AND EDUCATIONTO HOLD NATIONAL CONFERENCE ON PROSTATE CANCER

July, 2003 -- The National Conference on Prostate Cancer 2003 is for prostate cancer patients, survivors, family members and healthcare professionals. Internationally renowned researchers and specialists in the treatment of prostate cancer will speak to an anticipated draw of over 1,500 people.

"This conference will be the most significant and the only national conference on prostate cancer this year, directed at both patients and physicians, " says PCRI Executive Director Glenn Weaver. "We will have physicians and research scientists presenting the latest findings in their field of practice including diagnostic techniques, treatment options, nutrition, and new advances in the understanding and treatment of prostate cancer."

There will be free PSA screenings from on Friday, September 5, from 8:30 am to 1:30 pm, and on Saturday, September 6, from 8:00 am to 12 Noon.

The Friday (10:00 a. m. to 6:00 p.m.), Saturday (8:00 a.m. to 5:00 p.m.) and Sunday (8:30 a.m. to 4:00 p.m.) sessions will cover such vital subjects as endocrine applications in PC; PSA recurrence; intermittent androgen deprivation; advances in the chemotherapy of PC; Neoadjuvant hormone blockade and radiation therapy; remarkable advances in radiation therapy: IMRT & 3DCRT; bone integrity, bone marrow support, and pain control; emotional support and patient empowerment and a live demonstration of a Color Doppler Ultrasound and Biopsy will be performed on Saturday at 8:20 a.m. The speakers are renowned experts in the research and treatment of prostate cancer from throughout the United States. (List is attached).

The Conference is being sponsored by the Prostate Institute of America. Other collaborators and supporters are the American Cancer Society, the California Prostate Cancer Coalition, CaPCure, the Education Center for Prostate Cancer Patients, Inc., the National Prostate Cancer Coalition, Patient Advocates for Advanced Cancer Treatments, Inc., US TOO! International, and Community Memorial Hospital. The cost for the conference is $ 65.00 per person. To register and/or to obtain additional information call the PCRI at 310-743-2116 or logon to www.pcri.org.

The Prostate Cancer Research Institute is a not-for-profit 501 (c) (3) educational and research support organization founded in 1997. Its mission is to see that prostate cancer is no longer a threat to any man's life. PCRI is dedicated to educating the public about prostate cancer, pursuing research into the prevention and treatment of prostate cancer, and improving the present level of care for men with the disease. PCRI is a public charity.
For more information about the PCRI visit their Website at www.pcri.org.

National Conference on Prostate Cancer 2003 Speakers:

Charles E. Myers, Jr., M.D, Founder, American Institute for Diseases of the Prostate of the Foundation For Cancer Research And Education, Earlysville, VA.,

David G. Bostwick, M.D; Medical Director, Bostwick Laboratories, Richmond, VA; Clinical Professor of Pathologist, University of Virginia, Richmond, VA;

Clinical Professor of Pathology; Consultant, Urologic Oncology Division, National Cancer Institute (USA), Bethesda, MD

Michael J. Dattoli, M.D.; Dattoli Cancer Center and Brachytherapy Research Institute, Sarasota, FL

David Agus, M.D.; Research Director, Cedars-Sinai Prostate Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA

Duke Bahn, M.D.; Medical Director, Prostate Institute of America, Ventura, CA

Stan Brosman, M.D.; Urologist, Prostate Cancer Research Institute Advisor; Pacific Urology Institute, Santa Monica, CA

Donald Coffey, Ph.D.; Professor of Urology, Oncology, Pharmacology and Molecular Sciences; Director of Research Johns Hopkins University School of Medicine, Johns Hopkins Hospital, Baltimore, MD

David Heber, M.D.; UCLA Center for Human Nutrition, Los Angeles, CA

Samuel Kipper, M.D.; Director of PET and Nuclear Medicine, Pacific Coast Imaging, Irvine, CA

John Kurhanewicz, Ph.D.; UCSF Department of Radiology, San Francisco, CA

Richard Lam, M.D.; Medical Oncologist, Prostate Cancer Research Institute Advisor; Prostate Oncology Specialists, Marina del Rey, CA

Paul Lange, M.D.; University of Washington, Department of Urology, Seattle, WA

Gary Leach, M.D.; Tower Urology, Los Angeles, CA

Fred Lee, M.D.; Co-Director Prostate Center (Radiologist); Karmanos Cancer Institute at Wayne State University, Commerce Township, MI

"Dr. Bob" Leibowitz, M.D.; Medical Oncologist, Compassionate Oncology, Los Angeles, CA

Jon McDermed, PharmD; Diagnostic Products Corporation, Los Angeles, CA

Michael Milken; Founder, Chairman and President of CaPcure, Santa Monica, CA

Mark Scholz, M.D.; Medical Oncologist, Prostate Cancer Research Institute Medical Advisor; Prostate Oncology Specialists, Marina del Rey, CA

Howard Soule, Ph.D.; CaP CURE, Santa Monica, CA

Stephen B. Strum, M.D.; Medical Oncologist, Ashland, OR    





This article courtesy of http://www.doyouhavemesothelioma.com.
You may freely reprint this article on your website or in
your newsletter provided this courtesy notice and the author
name and URL remain intact.

Did you find what you are looking for? If NOT.. Try google.

Submit Your Article